Search by Drug Name or NDC

    NDC 00944-5001-10 OBIZUR Details

    OBIZUR

    OBIZUR is a KIT in the PLASMA DERIVATIVE category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is .

    Product Information

    NDC 00944-5001
    Product ID 0944-5001_6bf6b16a-d0f3-4643-b491-e75fa0f98ac5
    Associated GPIs 85100010502130
    GCN Sequence Number 073007
    GCN Sequence Number Description antihemophilic FVIII,rec porc VIAL 500 (+/-) INTRAVEN
    HIC3 M0E
    HIC3 Description ANTIHEMOPHILIC FACTORS
    GCN 37321
    HICL Sequence Number 041515
    HICL Sequence Number Description ANTIHEMOPHILIC FACTOR VIII, RECOMBINANT PORCINE SEQUENCE
    Brand/Generic Brand
    Proprietary Name OBIZUR
    Proprietary Name Suffix n/a
    Non-Proprietary Name Antihemophilic Factor (Recombinant), Porcine Sequence
    Product Type PLASMA DERIVATIVE
    Dosage Form KIT
    Route n/a
    Active Ingredient Strength n/a
    Active Ingredient Units n/a
    Substance Name n/a
    Labeler Name Takeda Pharmaceuticals America, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA125512
    Listing Certified Through 2024-12-31

    Package

    NDC 00944-5001-10 (00944500110)

    NDC Package Code 0944-5001-10
    Billing NDC 00944500110
    Package 10 CARTON in 1 CARTON (0944-5001-10) / 1 KIT in 1 CARTON (0944-5001-01) * 1 mL in 1 VIAL, GLASS (0944-5011-01) * 1 mL in 1 SYRINGE, GLASS (0944-0011-01)
    Marketing Start Date 2014-10-23
    NDC Exclude Flag N
    Pricing Information N/A